The Impact of GLP-1 Agonists on Depression Treatment: A Literature Review

Introduction Depression is increasingly recognized as a major global health issue, driven by neurobiological, genetic, and environmental factors. Despite extensive research, understanding depression remains challenging due to its complexity and the lack of biomarkers. Recent studies highlight a...

Full description

Bibliographic Details
Published in:	Journal of Education, Health and Sport
Main Authors:	Paulina Lemieszek, Katarzyna Rudnicka, Ilona Sajkiewicz, Nadia Miga-Orczykowska, Ilona Jasiuk, Justyna Wójtowicz, Martyna Pustelniak, Katarzyna Krukar, Ewa Łukaszewska, Klaudia Kister, Kamil Chrościński, Jakub Laskowski
Format:	Article
Language:	English
Published:	Kazimierz Wielki University 2024-10-01
Subjects:	GLP-1 diabetes depression systematic review
Online Access:	https://apcz.umk.pl/JEHS/article/view/55353

Similar Items

Current knowledge on irritable bowel syndrome treatment - literature overview
by: Ilona Jasiuk, et al.
Published: (2024-09-01)

Clinical use of Abemaciclib a cyclin-dependent kinase (CDK) 4/6 inhibitor in patients with breast cancer — literature review
by: Katarzyna Maria Krukar, et al.
Published: (2024-09-01)

Overview of Pilonidal Cyst Treatment Methods - Review Paper
by: Ewa Łukaszewska, et al.
Published: (2024-09-01)

Targeted Cancer Therapy: The Role of Liposomes in Oncology. A Literature Review
by: Katarzyna Rudnicka, et al.
Published: (2024-10-01)

The Importance of Supplementation in Vegan and Vegetarian Diets for Adults
by: Justyna Wójtowicz, et al.
Published: (2024-09-01)

The Role of Gut Microbiome in the Pathogenesis and Progression of Acute Pancreatitis
by: Nadia Miga-Orczykowska, et al.
Published: (2024-09-01)

Tirbanibulin as a Novel Treatment in Actinic Keratosis: A Literature Review
by: Ilona Sajkiewicz, et al.
Published: (2024-09-01)

Interactions Between the Gut Microbiome and Acute Pancreatitis
by: Nadia Miga-Orczykowska, et al.
Published: (2024-09-01)

Exploring the Therapeutic Potential of Sodium Butyrate in Irritable Bowel Syndrome. A Literature Review
by: Nadia Miga-Orczykowska, et al.
Published: (2024-09-01)

Comparison of Non-Surgical Methods for Treating Hemorrhoids
by: Nadia Miga, et al.
Published: (2024-09-01)

Transrectal ultrasound (TRUS) as a diagnostic tool for abscesses and fistulas of the anus. Anatomy and methodology of the TRUS examination
by: Ewa Łukaszewska, et al.
Published: (2024-09-01)

Danuglipron – an innovate GLP agonist - literature short review
by: Agata Frańczuk, et al.
Published: (2024-08-01)

GLP-1 Receptor Agonists’ Impact on Fertility - A Review
by: Joanna Wojda, et al.
Published: (2025-02-01)

Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists
by: Qiyuan Keith Liu
Published: (2024-07-01)

GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation
by: Giulia Migliorisi, et al.
Published: (2025-07-01)

The Impact of GLP1 Agonists on Bone Metabolism: A Systematic Review
by: Ioanna Daniilopoulou, et al.
Published: (2022-02-01)

Potential Use of GLP-1 and GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at?
by: Miodrag Janić, et al.
Published: (2024-12-01)

The Impact of GLP-1 Receptor Agonists on Women's Reproductive Health: A Review
by: Marta Wolszczak, et al.
Published: (2025-06-01)

Are GLP-1 Analogues a New Solution for the Treatment of NAFLD?
by: Maria Sudoł, et al.
Published: (2024-12-01)

Retatrutide - revolutionary recently developed GLP agonist - literature review
by: Patrycja Brzozowska, et al.
Published: (2024-07-01)

GLP-1 Receptor Agonists in Heart Failure
by: Ali Reza Rahmani, et al.
Published: (2025-10-01)

GLP-1 Agonists, Willpower, and Weight Stigma: A Paradigm Shift for Obesity
by: Pablo Arrona-Cardoza
Published: (2025-08-01)

Research Progress on the Association Between GLP-1 Receptor Agonists and Cardiomyopathy
by: Xiao Yang, et al.
Published: (2025-08-01)

Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of tirzepatide
by: Fatemeh Taktaz, et al.
Published: (2024-07-01)

Improving Reproductive Outcomes in PCOS: The Emerging Role of GLP-1 Receptor Agonists
by: Adrianna Tabeau, et al.
Published: (2025-03-01)

Comparative cardiovascular effects of GLP‐1 agonists using real‐world data
by: Amisha Wallia, et al.
Published: (2023-05-01)

Can GLP-1 receptor agonists slow the progression of Autosomal Dominant Polycystic Kidney Disease?
by: Hamad Ali, et al.
Published: (2025-06-01)

Dietary intake by patients taking GLP-1 and dual GIP/GLP-1 receptor agonists: A narrative review and discussion of research needs
by: Sandra Christensen, et al.
Published: (2024-09-01)

Could Increased Glp1r Expression via Sitagliptin in the GLP-1/GLP-1 Receptor Axis in the DietInduced Obesity Rat Model be Important in Liver Metabolism?
by: Cem Horozoğlu, et al.
Published: (2024-12-01)

SYNERGISTIC IMPACT OF EXERCISE AND GLP-1 RECEPTOR AGONIST TREATMENT: ADDRESSING METABOLIC SYNDROME, ABDOMINAL OBESITY, AND INFLAMMATION
by: Jakub Kuśmierski, et al.
Published: (2024-05-01)

Exploring the Role of GLP-1 Receptor Agonists in Alzheimer’s Disease: A Review of Preclinical and Clinical Evidence
by: Lívia C. R. Teixeira, et al.
Published: (2025-01-01)

The Beneficial Effects of GLP-1 Receptor Agonists Other than Their Anti-Diabetic and Anti-Obesity Properties
by: Chenqi Lu, et al.
Published: (2024-12-01)

GLP-1 analogs: a comparison of new anti diabetic medications - presenting benefits and risks
by: Marika Dębik, et al.
Published: (2024-02-01)

GLP1 Receptor Agonists—Effects beyond Obesity and Diabetes
by: Sydney S. Wilbon, et al.
Published: (2023-12-01)

Glucagon-like peptide-1 (GLP-1) agonists in the treatment of obesity
by: Magdalena Mazurek, et al.
Published: (2023-02-01)

Potential impact of GLP-1 receptor agonists on male fertility: a fable of caution
by: Stefan S. Du Plessis, et al.
Published: (2024-11-01)

REBOUND OBESITY AFTER GLP-1 AGONISTS DISCONTINUATION
by: Zainab M. Al-Shammaa, et al.
Published: (2025-07-01)

Out of stock: A brief clinical reference for rough equivalency of glucagon‐like peptide‐1 (GLP‐1) ± glucose‐dependent insulinotropic polypeptide (GIP) receptor agonists for A1c and weight reduction in people with type 2 diabetes
by: Leigh Perreault, et al.
Published: (2024-06-01)

Hormonal modulation, mitochondria and Alzheimer’s prevention: the role of GLP-1 agonists and estrogens
by: Fernando Lizcano, et al.
Published: (2025-06-01)

Comparative Effectiveness of Long-Acting GLP-1 Receptor Agonists in Type 2 Diabetes: A Short Review on the Emerging Data
by: Chudleigh RA, et al.
Published: (2020-02-01)